AngioDynamics Awarded $74.9 Million in Case Against biolitec AG
March 20, 2014 06:30 ET
|
AngioDynamics
ALBANY, N.Y., March 20, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Receives Expanded FDA Clearance for AngioVac
March 11, 2014 06:30 ET
|
AngioDynamics
ALBANY, N.Y., March 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Receives FDA Clearance for DuraMax Dialysis Catheter With BioFlo Technology to Reduce Catheter-Related Thrombus
March 07, 2014 06:30 ET
|
AngioDynamics
ALBANY, N.Y., March 7, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Updates U.S. Tip Location Strategy
March 06, 2014 16:01 ET
|
AngioDynamics
ALBANY, N.Y., March 6, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Present at the Barclays Global Healthcare Conference
March 03, 2014 07:00 ET
|
AngioDynamics
ALBANY, N.Y., March 3, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Reports Fiscal 2014 Second Quarter Financial Results
January 09, 2014 16:01 ET
|
AngioDynamics
Net sales of $88.6 million
GAAP income per share at break-even; Non-GAAP adjusted net income, excluding amortization, of $0.14 per share
Adjusted EBITDA of $12.7 million
Operating...
AngioDynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference
December 18, 2013 07:00 ET
|
AngioDynamics
ALBANY, N.Y., Dec. 18, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Report Fiscal 2014 Second Quarter Financial Results
December 12, 2013 07:00 ET
|
AngioDynamics
ALBANY, N.Y., Dec. 12, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Appoints John Soto Chief Commercial Officer
December 11, 2013 07:00 ET
|
AngioDynamics
ALBANY, N.Y., Dec. 11, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Comments on New Reimbursement Rate for Hospital-Based Varicose Vein Ablations
December 10, 2013 07:00 ET
|
AngioDynamics
ALBANY, N.Y., Dec. 10, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...